Sarepta Therapeutics Inc (SRPT)
Days of sales outstanding (DSO)
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Receivables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| DSO | days | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
December 31, 2024 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ —
= —
The days of sales outstanding (DSO) ratio for Sarepta Therapeutics Inc has been reported as "— days" for all the periods specified in the data provided. As the DSO ratio indicates the average number of days it takes for a company to collect payment after making a sale, a DSO of "— days" does not provide any specific insight into the company's accounts receivable management efficiency.
Without the actual DSO values, it is challenging to evaluate the company's credit and collection policies, the effectiveness of its accounts receivable turnover, or its ability to manage cash flow from sales efficiently. There may be various reasons for this missing data, such as the company not publicly disclosing this information or the data not being available at the time of analysis.
To gain a deeper understanding of Sarepta Therapeutics Inc's receivables management, it would be necessary to have access to the actual DSO values or other related financial information to perform a more in-depth analysis of the company's liquidity, efficiency, and overall financial health.
Peer comparison
Dec 31, 2024